Recent MDGL News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:00:21 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 11:30:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 10:07:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2024 09:36:37 PM
- Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 12:01:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:47:55 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2024 08:32:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2024 01:02:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 11:05:30 AM
- Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 10/31/2024 11:00:00 AM
- Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting® • GlobeNewswire Inc. • 10/30/2024 12:00:22 PM
- Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis • GlobeNewswire Inc. • 10/21/2024 12:00:00 PM
- Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024 • GlobeNewswire Inc. • 10/18/2024 12:00:00 PM
- Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference • GlobeNewswire Inc. • 10/02/2024 12:00:00 PM
- Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development • GlobeNewswire Inc. • 10/01/2024 12:00:00 PM
- Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom) • GlobeNewswire Inc. • 09/30/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 01:51:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 01:29:06 AM
- Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:16:25 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 11:52:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 12:58:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:06:32 AM
- Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM